About Life Sciences
Bain Capital Life Sciences invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies globally, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs.
The differentiated skillset of Bain Capital’s team enables it to pursue opportunities created by several longterm trends in healthcare. In particular, these trends are creating an increased need for targeted capital and value-added strategic support of companies around their critical phases of growth, during which they must prove their clinical and business value.
Since 1984, Bain Capital has employed a strategic, analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Bain Capital has developed global reach, deep expertise and a proven track record in the life sciences industries across its Private Equity, Public Equity, Credit, and Ventures business units.
Focused strategy across four themes of investments
Bain Capital Life Sciences targets four types of investment opportunities:
Inflection Capital
Engagement with companies at the critical development stages of innovation
Growth Capital
Partnering with companies to accelerate and expand platforms
Fallen Angels
Engaging with companies at a crossroads to create value.
Larger Private Equity
Collaborating with the Bain Capital platform to invest in and support larger companies
Guiding Principles
Bain Capital Life Sciences seeks to create differentiated value by identifying investments across a broad spectrum of opportunities:
Targeting companies that drive innovation across the healthcare value chain
Bringing breakthrough advances to market that improve the lives of patients
Enabling efficient use of capital through rigorous diligence, asset selection and value-added support
“Bain Capital Life Sciences provides targeted and value-added support to pursue innovation that improves the lives of patients.”
Contact Us
For additional information, please contact lifesciencesir@baincapital.com.